|
Name |
7-methyl-2-(1-methylethylidene)furo[3,2-h]isoquinolin-3(2H)-one
|
Molecular Formula | C15H13NO2 | |
IUPAC Name* |
7-methyl-2-propan-2-ylidenefuro[3,2-h]isoquinolin-3-one
|
|
SMILES |
CC1=CC2=C(C=N1)C3=C(C=C2)C(=O)C(=C(C)C)O3
|
|
InChI |
InChI=1S/C15H13NO2/c1-8(2)14-13(17)11-5-4-10-6-9(3)16-7-12(10)15(11)18-14/h4-7H,1-3H3
|
|
InChIKey |
KJJZKDAMKKPUPJ-UHFFFAOYSA-N
|
|
Synonyms |
7-methyl-2-(1-methylethylidene)furo[3,2-h]isoquinolin-3(2H)-one; CHEMBL332745; TMC-120B; TMC-120-B; 7-methyl-2-propan-2-ylidenefuro[3,2-h]isoquinolin-3-one; furo[3,2-h]isoquinolin-3(2H)-one, 7-methyl-2-(1-methylethylidene)-
|
|
CAS | NA | |
PubChem CID | 640952 | |
ChEMBL ID | CHEMBL332745 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 239.27 | ALogp: | 3.5 |
HBD: | 0 | HBA: | 3 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 39.2 | Aromatic Rings: | 3 |
Heavy Atoms: | 18 | QED Weighted: | 0.648 |
Caco-2 Permeability: | -4.818 | MDCK Permeability: | 0.00001790 |
Pgp-inhibitor: | 0.007 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.004 |
30% Bioavailability (F30%): | 0.004 |
Blood-Brain-Barrier Penetration (BBB): | 0.018 | Plasma Protein Binding (PPB): | 91.48% |
Volume Distribution (VD): | 0.87 | Fu: | 9.54% |
CYP1A2-inhibitor: | 0.977 | CYP1A2-substrate: | 0.82 |
CYP2C19-inhibitor: | 0.408 | CYP2C19-substrate: | 0.173 |
CYP2C9-inhibitor: | 0.473 | CYP2C9-substrate: | 0.485 |
CYP2D6-inhibitor: | 0.583 | CYP2D6-substrate: | 0.798 |
CYP3A4-inhibitor: | 0.449 | CYP3A4-substrate: | 0.146 |
Clearance (CL): | 8.122 | Half-life (T1/2): | 0.303 |
hERG Blockers: | 0.01 | Human Hepatotoxicity (H-HT): | 0.894 |
Drug-inuced Liver Injury (DILI): | 0.981 | AMES Toxicity: | 0.395 |
Rat Oral Acute Toxicity: | 0.84 | Maximum Recommended Daily Dose: | 0.544 |
Skin Sensitization: | 0.734 | Carcinogencity: | 0.811 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.052 |
Respiratory Toxicity: | 0.949 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003392 | 0.569 | D0FA2O | 0.260 | ||||
ENC002641 | 0.515 | D09MGR | 0.258 | ||||
ENC001953 | 0.493 | D0G5UB | 0.250 | ||||
ENC002979 | 0.457 | D01PZD | 0.247 | ||||
ENC002640 | 0.443 | D07JGT | 0.247 | ||||
ENC002485 | 0.437 | D08SKH | 0.247 | ||||
ENC002693 | 0.419 | D03GET | 0.246 | ||||
ENC004986 | 0.419 | D0G4KG | 0.241 | ||||
ENC003543 | 0.337 | D0J6WW | 0.239 | ||||
ENC004956 | 0.314 | D03ZBN | 0.238 |